相关实验视频
Updated: Jul 25, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
275
通过结构和分子成像来预测老年人的认知衰退
Stefan Teipel1,2, Yi Tang3, Marina Boccardi1,2
1Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE).
Current opinion in neurology
|June 29, 2023
概括
图像化生物标志物在认知正常个体中对阿尔茨海默病 (AD) 的预测价值有限. 然而,在轻度认知障碍 (MCI) 中,这些标记物,特别是粉样蛋白PET,为临床咨询提供了有价值的预后信息.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 疾病修饰治疗的出现和在阿尔茨海默氏症 (AD) 中识别先发性病阶段强调了生物标志物的预后意义,特别是成像标志物.
- 预测AD进展的成像生物标志物的临床实用性正在积极调查中.
结论:
- 对于患有MCI的人来说,粉样蛋白PET,蛋白PET,FDG-PET和MRI为专门诊断计划中的临床咨询提供了相关的预测准确性.
- 未来的研究应该优先考虑以系统和以患者为中心的成像标记物的集成,将其纳入基于证据的护理途径,以帮助患有前发性AD的个体.
相关概念视频
Brain Imaging
263
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
263
Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
Alzheimer's Disease: Overview
530
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
530

